418

Submitted by admin on
Action
ERBB2
Alt Name
Perjeta
Omnitarg
Approval Jurisdiction
2012 FDA 2013 EMA
Approved for clinical use
HER2-positive breast cancer
CAS
380610-27-5
Commercial Vendor
Genentech
Compound Image
Pertuzumab.png
Compound name
Pertuzumab
Approved Drug List
1